People
There’s no doubt that drug prices, particularly sky-high prices for new biologics and companies jacking up the prices of older drugs, is a problem. And it’s definitely a political issue, especially now that candidates are declaring their plans to run for president in 2020.
Philadelphia PA and Sydney Australia, 12 February 2019: Medical dermatology company Botanix Pharmaceuticals Limited is pleased to announce the appointment of Dr Michael Thurn, Head of Australian Operations, as Executive Director.
Recipharm, the contract development and manufacturing organisation, has appointed a new director of business management for the USA and Canada to accelerate growth in the region.
Dr. Anikeeva, a neural engineer, is an Associate Investigator at the McGovern Institute for Brain Research at Massachusetts Institute of Technology (MIT). She’s an Associate Professor of Materials Science, Engineering, and Brain and Cognitive Sciences as well as an Associate Director of the Research Laboratory of Electronics.
Medigene AG announced that its Supervisory Board has appointed Axel-Sven Malkomes as Chief Financial Officer and Chief Business Development Officer effective 1 April 2019.
In an exclusive interview with BioSpace, Iovance CEO Maria Fardis said the company’s goal is to add headcount to support its growth strategy. The company currently has about 100 full-time employees.
When biotech companies post openings for new positions, hiring managers often face the immense task of sorting through numerous resumes of qualified candidates. However, in South Korea, hiring managers are facing a different problem – a dearth of qualified candidates.
Alexander (Sasha) Opotowsky, associate professor at Harvard Medical School and a cardiologist at Boston Children’s Hospital and Brigham and Women’s Hospital took time out to speak with BioSpace about advances in heart health, congenital heart disease (CHD), biopharma, and the Adult Congenital Heart Association (ACHA).
Thomas Wicks, chief strategy officer of New Jersey-based TrialScope, said transparency has picked up over the past few years, particularly as large pharma companies have begun to release information about their own clinical efforts.
In this week’s edition of Movers and Shakers, biopharma companies tap executives to serve in various leadership roles.
PRESS RELEASES